Literature DB >> 9143709

H2-M3, a full-service class Ib histocompatibility antigen.

K F Lindahl1, D E Byers, V M Dabhi, R Hovik, E P Jones, G P Smith, C R Wang, H Xiao, M Yoshino.   

Abstract

H2-M3 is an MHC class Ib molecule of the mouse with a unique preference for N-formylated peptides, which may come from the N-termini of endogenous, mitochondrial proteins or foreign, bacterial proteins. The crystal structure of M3 revealed a hydrophobic peptide-binding groove with an occluded A pocket and the peptide shifted one residue relative to class Ia structures. The formyl group is held by a novel hydrogen bonding network, involving His9 on the bottom of the groove, and the side chain of the P1 methionine is lodged in the B pocket. M3 is a full-service histocompatibility (H) antigen, i.e. self-M3 can present endogenous peptides as minor H antigens and foreign, bacterial antigens in a defensive immune response to infection; and foreign M3 complexed with endogenous self-peptides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143709     DOI: 10.1146/annurev.immunol.15.1.851

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  30 in total

Review 1.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Comparative genomics of the human, macaque and mouse major histocompatibility complex.

Authors:  Takashi Shiina; Antoine Blancher; Hidetoshi Inoko; Jerzy K Kulski
Journal:  Immunology       Date:  2016-07-10       Impact factor: 7.397

3.  Requirements for the selective degradation of endoplasmic reticulum-resident major histocompatibility complex class I proteins by the viral immune evasion molecule mK3.

Authors:  Xiaoli Wang; Rose Connors; Michael R Harris; Ted H Hansen; Lonnie Lybarger
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Cross-recognition of N-formylmethionine peptides is a general characteristic of H2-M3-restricted CD8+ T cells.

Authors:  Alexander Ploss; An Tran; Ewa Menet; Ingrid Leiner; Eric G Pamer
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Global expression profiling of peripheral Qa-1-restricted CD8αα+TCRαβ+ regulatory T cells reveals innate-like features: implications for immune-regulatory repertoire.

Authors:  Shaohsuan S Fanchiang; Radu Cojocaru; Mohammad Othman; Ritu Khanna; Matthew J Brooks; Trevor Smith; Xiaolei Tang; Igor Maricic; Anand Swaroop; Vipin Kumar
Journal:  Hum Immunol       Date:  2011-08-17       Impact factor: 2.850

6.  H2-M3 major histocompatibility complex class Ib-restricted CD8 T cells induced by Salmonella enterica serovar Typhimurium infection recognize proteins released by Salmonella serovar Typhimurium.

Authors:  S Ugrinovic; C G Brooks; J Robson; B A Blacklaws; C E Hormaeche; J H Robinson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Species-specific class I gene expansions formed the telomeric 1 mb of the mouse major histocompatibility complex.

Authors:  Toyoyuki Takada; Attila Kumánovics; Claire Amadou; Masayasu Yoshino; Elsy P Jones; Maria Athanasiou; Glen A Evans; Kirsten Fischer Lindahl
Journal:  Genome Res       Date:  2003-04       Impact factor: 9.043

8.  Isolation of major histocompatibility complex Class I genes from the tammar wallaby (Macropus eugenii).

Authors:  Hannah V Siddle; Janine E Deakin; Michelle L Baker; Robert D Miller; Katherine Belov
Journal:  Immunogenetics       Date:  2006-03-28       Impact factor: 2.846

9.  Sequence, expression, and polymorphism of the Peromyscus leucopus Mhc class Ib gene, M4.

Authors:  Mark D Crew; Linda M Bates
Journal:  Immunogenetics       Date:  2003-04-17       Impact factor: 2.846

Review 10.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.